The number of novel medical devices brought to market continues to grow; keeping up with reviews will remain an ongoing challenge for the FDA. … READ MORE >
5 things to know in life sciences: Week of Jan. 31, 2022
From the rapid rise of a telehealth pharmacy to calls to increase clinical trial cost disclosures, each week we highlight five things to know in life sciences. … READ MORE >
5 things to know in life sciences: Week of Jan. 24
From ethical questions for neurologists and clinical research to an omicron-focused vaccine, each week we highlight five things to know in life sciences. … READ MORE >
5 things to know in life sciences: Week of Jan. 17, 2022
From the impact of antimicrobial-resistant diseases to the demand for decentralized clinical trials, each week we highlight five things you need to know in the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of Jan. 10
This week we highlight a flood of studies and approvals with a focus on leveraging new technologies, data and gene sequencing to increase patient care. … READ MORE >
5 things to know in life sciences: Week of Jan. 3
This week we explore a partnership between a large biopharma and a machine learning startup along with other developments impacting the life sciences industry. … READ MORE >
Five things to know in life sciences: Week of Dec. 13
From eye drops that replace glasses to a new Pfizer facility focused on gene therapy, each week we highlight five things to know in life sciences. Here’s the latest. … READ MORE >
Five things to know in life sciences: Week of Dec. 6
From leadless pacemakers to a possible new Alzheimer’s treatment, each week we highlight five things impacting the life sciences industry. … READ MORE >
Five things we don’t know about omicron: Week of November 29
This week it is unavoidable not to mention omicron and so we’ve decided to dedicate our issue of “5 things in life sciences” to this very topic. … READ MORE >
5 things to know in life sciences: Week of November 15
From a new virtual reality system to treat chronic back pain to sustainable pharmaceuticals, each week we highlight five things impacting the life sciences industry. … READ MORE >